Carregant...
Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor ß levels in rheumatoid arthritis
Methods: Plasma levels of TGFß1 and TGFß2 were determined in 26 patients with RA during six months of etanercept treatment and compared with disease activity and laboratory parameters, including matrix metalloproteinase-3 (MMP-3) and interleukin 6 (IL6). Results: Before treatment all patients had ra...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2002
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1754023/ https://ncbi.nlm.nih.gov/pubmed/11830433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.61.3.254 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|